. Author manuscript; available in PMC: 2019 Jul 1.

Published in final edited form as: Clin Gastroenterol Hepatol. 2018 Apr 26;17(1):156–163.e2. doi: 10.1016/j.cgh.2018.04.043

Table 3.

AUROCs by length of time between VCTE exam and biopsy *not cross-validated

Predictor	Outcome	AUROC*		P-value from test of independence of AUROCs
		VCTE exam and biopsy within 30 days (n=119)	VCTE exam and biopsy outside of 30 days (n=274)	P-value from test of independence of AUROCs
LSM	Fibrosis stage 0 vs 1–4	0.76	0.75	0.85
	Fibrosis stage 0–1 vs 2–4	0.76	0.80	0.44
	Fibrosis stage 0–2 vs 3–4	0.87	0.82	0.27
	Fibrosis stage 0–3 vs 4	0.95	0.93	0.56
CAP	Steatosis grade 0 vs 1–3	0.86	0.75	0.33
	Steatosis grade 0–1 vs 2–3	0.77	0.67	0.09
	Steatosis grade 0–2 vs 3	0.63	0.58	0.41